Brief: DOMA Perpetual Supports Pacira's New $300 Million Share Repurchase Authorization As A Meaningful Step To Enhance Value For Shareholders
21/04/2025 13:17
April 21 (Reuters) - Pacira Biosciences Inc PCRX.O: DOMA PERPETUAL SUPPORTS PACIRA'S NEW $300 MILLION SHARE REPURCHASE AUTHORIZATION AS A MEANINGFUL STEP TO ENHANCE VALUE FOR SHAREHOLDERS DOMA PERPETUAL - BELIEVES PACIRA'S STOCK IS UNDERVALUED DOMA PERPETUAL - OWNS 4.2% OF PACIRA BIOSCIENCES Source text: ID:nPn748T7Ya Further company coverage: PCRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pacira Biosciences
See all newsBrief: Pacira Biosciences Inc - Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "For" All Of Pacira's Director Nominees
Brief: Pacira Biosciences Urges Stockholders To Vote "For" Election Of Pacira's Nominees On Blue Proxy Card
Brief: Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy
Brief: Doma Perpetual Capital Management Calls For Removal Of Pacira CEO And Strategic Sale
Brief: Pacira Biosciences Sends Letter To Stockholders Reiterating Superior Qualifications Of Its Board Nominees